Kathryn Kellohen

PharmD @UCSFPharmacy | PGY-1 @UICPhPr | EM PGY-2 @StanfordHealth

[Lance Ray @LRayRx]

Amiodarone isn’t the answer just because it’s listed first.
Let’s give lidocaine some love!!
Our @AnnalsofEM commentary lays out the argument for lidocaine in VT/VF arrest. Time to rethink your ACLS autopilot. #TwitteRx #EMRx
Free access link: https://t.co/spkTpck1YI

[Ruben Santiago, PharmD @ThePeoplesRuben]

Is this study practice changing???? Who is still team PCC and who is still/new convert to team AA?

[Joshua Park, PharmD @joshparkpharmd]

So proud of @kkellohen on her excellent presentation on sugammadex for neuromuscular blockade reversal in the ED at #SAEM24. Great job!!!

[Deepika Sivakumar @dsivapharmd]

Congratulations @Sssofeso_27 for a great presentation! Also congrats @BryanGPharmD @NatalijaFarrell #twitterlessjesscorio glad we were able to face time you in for some of the fun! 😏

[ACCP EMED PRN @accpemedprn]

@daijahd_pharmd Dr. Kathryn Kellohen, PGY2 EM Resident from Stanford Health Care, will be discussing the RAPID trial which studied self-administered 👃 etripamil for AV-nodal dependent SVT 🫀 @kkellohen #EMRx #TwitteRx https://t.co/WSQw572OPR

[Yumi Oh @yumioh797]

Going to miss our little huddles in B16 🥹

[Kathryn Kellohen @kkellohen]

@DangEMPharm @StanfordHealth Thank you for the warm welcome - so excited to join the team!! 🎉

[Brian Dang @DangEMPharm]

Welcoming our incoming PGY-2 EM resident @kkellohen to 🌲@StanfordHealth🌲, #TwitterRx and #EmergencyMedicine!!!